Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

LEISHMANICIDAL ACTIVITY OF ISOSELENOCYANATE DERIVATIVES.

Fernández-Rubio C, Larrea E, Peña Guerrero J, Sesma Herrero E, Gamboa I, Berrio C, Plano D, Amin S, Sharma AK, Nguewa PA.

Antimicrob Agents Chemother. 2018 Nov 26. pii: AAC.00904-18. doi: 10.1128/AAC.00904-18. [Epub ahead of print]

PMID:
30478164
2.

Double role of metalloporphyrins in catalytic bioinspired supramolecular metal-organic frameworks (SMOFs).

Fidalgo-Marijuan A, Amayuelas E, Barandika G, Larrea ES, Bazán B, Urtiaga MK, Iglesias M, Arriortua MI.

IUCrJ. 2018 Jul 20;5(Pt 5):559-568. doi: 10.1107/S2052252518007856. eCollection 2018 Sep 1.

3.

Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.

Schwartz J, Moreno E, Calvo A, Blanco L, Fernández-Rubio C, Sanmartín C, Nguewa P, Irache JM, Larrea E, Espuelas S.

J Dermatol Sci. 2018 Oct;92(1):78-88. doi: 10.1016/j.jdermsci.2018.07.005. Epub 2018 Jul 17.

PMID:
30037731
4.

Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases.

Goicoechea I, Rezola R, Arestin M, M Caffarel M, Cortazar AR, Manterola L, Fernandez-Mercado M, Armesto M, Sole C, Larrea E, M Araujo A, Ancizar N, Plazaola A, Urruticoechea A, Carracedo A, Ruiz I, Alvarez Lopez I, H Lawrie C.

Version 2. F1000Res. 2017 Aug 30 [revised 2018 Jan 1];6:1606. doi: 10.12688/f1000research.12393.2. eCollection 2017.

5.

Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma.

Manterola L, Aguirre P, Larrea E, Arestín M, Gaafar A, Elorriaga K, Goicoechea I, Armesto M, Fernández-Mercado M, Zabalza I, López-Duque JC, Larruskain E, Sistiaga JA, Landa M, Zabala A, Santaolalla F, Municio JA, Ispizua Á, García-Pedrero JM, Rodrigo JP, Lawrie CH.

Sci Rep. 2018 Apr 26;8(1):6613. doi: 10.1038/s41598-018-24780-7.

6.

Open and closed forms of the interpenetrated [Cu2(Tae)(Bpa)2](NO3)2·nH2O: magnetic properties and high pressure CO2/CH4 gas sorption.

Fernández de Luis R, Larrea ES, Orive J, Fidalgo-Marijuan A, Lezama L, Arriortua MI.

Dalton Trans. 2018 Jan 15;47(3):958-970. doi: 10.1039/c7dt04081d.

PMID:
29260169
7.

Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.

Lawrie CH, Armesto M, Fernandez-Mercado M, Arestín M, Manterola L, Goicoechea I, Larrea E, Caffarel MM, Araujo AM, Sole C, Sperga M, Alvarado-Cabrero I, Michal M, Hes O, López JI.

J Mol Diagn. 2018 Jan;20(1):34-45. doi: 10.1016/j.jmoldx.2017.09.002. Epub 2017 Oct 19.

PMID:
29056573
8.

Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.

Moreno E, Schwartz J, Calvo A, Blanco L, Larrea E, Irache JM, Sanmartín C, Coulman SA, Soto M, Birchall JC, Espuelas S.

Int J Pharm. 2017 Nov 25;533(1):236-244. doi: 10.1016/j.ijpharm.2017.09.055. Epub 2017 Sep 28.

PMID:
28964902
9.

miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.

Solé C, Larrea E, Di Pinto G, Tellaetxe M, Lawrie CH.

Cancer Lett. 2017 Oct 1;405:79-89. doi: 10.1016/j.canlet.2017.07.020. Epub 2017 Jul 27. Review.

PMID:
28757417
10.

Construction of Two mCherry Plasmids (pXG-mCherry) for Transgenic Leishmania: Valuable Tools for Future Molecular Analysis.

Vacas A, Sugden C, Velasco-Rodriguez Ó, Algarabel-Olona M, Peña-Guerrero J, Larrea E, Fernández-Rubio C, Nguewa PA.

J Parasitol Res. 2017;2017:1964531. doi: 10.1155/2017/1964531. Epub 2017 Feb 13.

11.
12.

Commensurate Superstructure of the {Cu(NO3)(H2O)}(HTae)(Bpy) Coordination Polymer: An Example of 2D Hydrogen-Bonding Networks as Magnetic Exchange Pathway.

Fernández de Luis R, Larrea ES, Orive J, Lezama L, Arriortua MI.

Inorg Chem. 2016 Nov 21;55(22):11662-11675. Epub 2016 Nov 2.

PMID:
27805389
13.

Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function.

Vasquez M, Fioravanti J, Aranda F, Paredes V, Gomar C, Ardaiz N, Fernandez-Ruiz V, Méndez M, Nistal-Villan E, Larrea E, Gao Q, Gonzalez-Aseguinolaza G, Prieto J, Berraondo P.

Oncoimmunology. 2016 Jun 29;5(8):e1196309. doi: 10.1080/2162402X.2016.1196309. eCollection 2016 Aug.

14.

Aberrant expression of MicroRNAs in B-cell lymphomas.

Sole C, Larrea E, Manterola L, Goicoechea I, Armesto M, Arestin M, Caffarel M, Araujo A, Fernandez M, Araiz M, Lawrie C.

Microrna. 2016 Aug 25. [Epub ahead of print]

PMID:
27568793
15.

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Larrea E, Sole C, Manterola L, Goicoechea I, Armesto M, Arestin M, Caffarel MM, Araujo AM, Araiz M, Fernandez-Mercado M, Lawrie CH.

Int J Mol Sci. 2016 Apr 27;17(5). pii: E627. doi: 10.3390/ijms17050627. Review.

16.

A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling.

Nistal-Villan E, Poutou J, Rodríguez-Garcia E, Buñuales M, Carte-Abad B, Prieto J, Gonzalez-Aseguinolaza G, Hernandez-Alcoceba R, Larrea E.

PLoS One. 2016 Mar 23;11(3):e0152031. doi: 10.1371/journal.pone.0152031. eCollection 2016.

17.

Crystal structure of K0.75[Fe(II) 3.75Fe(III) 1.25(HPO3)6]·0.5H2O, an open-framework iron phosphite with mixed-valent Fe(II)/Fe(III) ions.

Larrea ES, Mesa JL, Legarra E, Aguayo AT, Arriortua MI.

Acta Crystallogr E Crystallogr Commun. 2016 Jan 1;72(Pt 1):63-5. doi: 10.1107/S2056989015024007. eCollection 2016 Jan 1.

18.

Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model.

Nistal-Villan E, Bunuales M, Poutou J, Gonzalez-Aparicio M, Bravo-Perez C, Quetglas JI, Carte B, Gonzalez-Aseguinolaza G, Prieto J, Larrea E, Hernandez-Alcoceba R.

Mol Cancer. 2015 Dec 16;14:210. doi: 10.1186/s12943-015-0479-x.

19.

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.

Zabaleta A, Riezu-Boj JI, Larrea E, Villanueva L, Lasarte JJ, Guruceaga E, Fisicaro P, Ezzikouri S, Missale G, Ferrari C, Benjelloun S, Prieto J, Sarobe P.

J Med Virol. 2016 May;88(5):843-51. doi: 10.1002/jmv.24399. Epub 2015 Oct 19.

PMID:
26447929
20.

Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.

Moreno E, Schwartz J, Larrea E, Conde I, Font M, Sanmartín C, Irache JM, Espuelas S.

Nanomedicine. 2015 Nov;11(8):2003-12. doi: 10.1016/j.nano.2015.07.011. Epub 2015 Aug 15.

PMID:
26282379
21.

The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.

Fernandez-Mercado M, Manterola L, Larrea E, Goicoechea I, Arestin M, Armesto M, Otaegui D, Lawrie CH.

J Cell Mol Med. 2015 Oct;19(10):2307-23. doi: 10.1111/jcmm.12625. Epub 2015 Jun 27. Review.

22.

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection.

Zabaleta A, D'Avola D, Echeverria I, Llopiz D, Silva L, Villanueva L, Riezu-Boj JI, Larrea E, Pereboev A, Lasarte JJ, Rodriguez-Lago I, Iñarrairaegui M, Sangro B, Prieto J, Sarobe P.

Mol Ther Methods Clin Dev. 2015 Mar 11;2:15006. doi: 10.1038/mtm.2015.6. eCollection 2015.

23.

A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response.

Nistal-Villán E, Rodríguez-García E, Di Scala M, Ferrero-Laborda R, Olagüe C, Vales Á, Carte-Abad B, Crespo I, García-Sastre A, Prieto J, Larrea E, González-Aseguinolaza G.

J Innate Immun. 2015;7(5):466-81. doi: 10.1159/000375262. Epub 2015 May 5.

24.

Crystal structure of (NH4)2[Fe(II) 5(HPO3)6], a new open-framework phosphite.

Berrocal T, Mesa JL, Larrea E, Arrieta JM.

Acta Crystallogr Sect E Struct Rep Online. 2014 Oct 8;70(Pt 11):309-11. doi: 10.1107/S1600536814021783. eCollection 2014 Nov 1.

25.

Heterogeneous catalytic properties of unprecedented μ-O-[FeTCPP]2 dimers (H2TCPP = meso-tetra(4-carboxyphenyl)porphyrin): an unusual superhyperfine EPR structure.

Fidalgo-Marijuan A, Barandika G, Bazán B, Urtiaga MK, Larrea ES, Iglesias M, Lezama L, Arriortua MI.

Dalton Trans. 2015 Jan 7;44(1):213-22. doi: 10.1039/c4dt02250e.

PMID:
25371170
26.

A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system.

Aranda A, Bezunartea J, Casales E, Rodriguez-Madoz JR, Larrea E, Prieto J, Smerdou C.

Cell Mol Life Sci. 2014 Dec;71(23):4637-51. doi: 10.1007/s00018-014-1631-2. Epub 2014 May 3.

PMID:
24794511
27.

Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.

Larrea E, Echeverria I, Riezu-Boj JI, Aldabe R, Guembe L, Sola I, Civeira MP, Sarobe P, Prieto J.

J Hepatol. 2014 Mar;60(3):482-9. doi: 10.1016/j.jhep.2013.10.016. Epub 2013 Oct 26.

PMID:
24418171
28.

Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.

Lawrie CH, Larrea E, Larrinaga G, Goicoechea I, Arestin M, Fernandez-Mercado M, Hes O, Cáceres F, Manterola L, López JI.

J Pathol. 2014 Jan;232(1):32-42. doi: 10.1002/path.4296.

PMID:
24155122
29.

Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes.

Moreno D, Balasiddaiah A, Lamas O, Duret C, Neri L, Guembe L, Galarraga M, Larrea E, Daujat-Chavanieu M, Muntane J, Maurel P, Riezu JI, Prieto J, Aldabe R.

PLoS One. 2013 Sep 24;8(9):e74948. doi: 10.1371/journal.pone.0074948. eCollection 2013.

30.

Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.

Larrea E, Riezu-Boj JI, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A, Gastaminza P, Civeira MP, Sarobe P, Prieto J.

Gut. 2014 Apr;63(4):665-73. doi: 10.1136/gutjnl-2012-304377. Epub 2013 Jun 20.

PMID:
23787026
31.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

Sangro B, Gomez-Martin C, de la Mata M, Iñarrairaegui M, Garralda E, Barrera P, Riezu-Boj JI, Larrea E, Alfaro C, Sarobe P, Lasarte JJ, Pérez-Gracia JL, Melero I, Prieto J.

J Hepatol. 2013 Jul;59(1):81-8. doi: 10.1016/j.jhep.2013.02.022. Epub 2013 Mar 4.

PMID:
23466307
32.

Thermal response, catalytic activity, and color change of the first hybrid vanadate containing Bpe guest molecules.

Fernández de Luis R, Urtiaga MK, Mesa JL, Larrea ES, Iglesias M, Rojo T, Arriortua MI.

Inorg Chem. 2013 Mar 4;52(5):2615-26. doi: 10.1021/ic302662x. Epub 2013 Feb 14.

PMID:
23409737
33.

Validation of an antiviral assay method for quantifying IFN-α5 activity in macaque and human serum.

Arbillaga L, Murillo-Arbizu M, González I, Gil AG, Vettorazzi A, González-Peñas E, Larrea E, de Cerain AL.

Bioanalysis. 2013 Feb;5(3):289-305. doi: 10.4155/bio.12.313.

34.

Amine templated open-framework vanadium(III) phosphites with catalytic properties.

Orive J, Larrea ES, Fernández de Luis R, Iglesias M, Mesa JL, Rojo T, Arriortua MI.

Dalton Trans. 2013 Apr 7;42(13):4500-12. doi: 10.1039/c2dt32286b.

PMID:
23340960
35.

Synthesis and comparative study of Co(pym)(VO3)2 and [Co(H2O)2(VO3)2]·2H2O.

Larrea ES, Mesa JL, Pizarro JL, Fernández de Luis R, Rodríguez Fernández J, Rojo T, Arriortua MI.

Dalton Trans. 2012 Dec 14;41(46):14170-9. doi: 10.1039/c2dt31531a. Epub 2012 Oct 4.

PMID:
23034532
36.

CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.

Hervas-Stubbs S, Mancheño U, Riezu-Boj JI, Larraga A, Ochoa MC, Alignani D, Alfaro C, Morales-Kastresana A, Gonzalez I, Larrea E, Pircher H, Le Bon A, Lopez-Picazo JM, Martín-Algarra S, Prieto J, Melero I.

J Immunol. 2012 Oct 1;189(7):3299-310. Epub 2012 Aug 27.

37.

N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18.

38.

Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B.

Otano I, Suarez L, Dotor J, Gonzalez-Aparicio M, Crettaz J, Olagüe C, Vales A, Riezu JI, Larrea E, Borras F, Benito A, Hernandez-Alcoceba R, Menne S, Prieto J, González-Aseguinolaza G.

Hepatology. 2012 Aug;56(2):474-83. doi: 10.1002/hep.25667. Epub 2012 Jul 2.

PMID:
22334260
39.

Flexible and dynamic thermal behavior of self-catenated [{Ni3(H2O)3(Bpa)4}(V6O18)]·8H2O constructed from 10-c heterometallic inorganic-organic clusters.

Fernández de Luis R, Mesa JL, Urtiaga MK, Larrea ES, Rojo T, Arriortua MI.

Inorg Chem. 2012 Feb 20;51(4):2130-9. doi: 10.1021/ic201951e. Epub 2012 Feb 3.

PMID:
22303905
40.

M(C6H16N3)2(VO3)4 as heterogeneous catalysts. Study of three new hybrid vanadates of cobalt(II), nickel(II) and copper(II) with 1-(2-aminoethyl)piperazonium.

Larrea ES, Mesa JL, Pizarro JL, Iglesias M, Rojo T, Arriortua MI.

Dalton Trans. 2011 Dec 21;40(47):12690-8. doi: 10.1039/c1dt10971e. Epub 2011 Oct 14.

PMID:
22002670
41.

Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin.

Tuñon MJ, San Miguel B, Crespo I, Riezu-Boj JI, Larrea E, Alvarez M, González I, Bustos M, González-Gallego J, Prieto J.

J Virol. 2011 Dec;85(24):13124-32. doi: 10.1128/JVI.05725-11. Epub 2011 Oct 5.

42.

Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties.

Fioravanti J, González I, Medina-Echeverz J, Larrea E, Ardaiz N, González-Aseguinolaza G, Prieto J, Berraondo P.

Hepatology. 2011 Jun;53(6):1864-73. doi: 10.1002/hep.24306. Epub 2011 May 2.

PMID:
21425312
43.

Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.

Díaz-Valdés N, Manterola L, Belsúe V, Riezu-Boj JI, Larrea E, Echeverria I, Llópiz D, López-Sagaseta J, Lerat H, Pawlotsky JM, Prieto J, Lasarte JJ, Borrás-Cuesta F, Sarobe P.

Hepatology. 2011 Jan;53(1):23-31. doi: 10.1002/hep.23980. Epub 2010 Dec 13.

44.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.

45.

Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8(+) T cells.

Hervas-Stubbs S, Riezu-Boj JI, Gonzalez I, Mancheño U, Dubrot J, Azpilicueta A, Gabari I, Palazon A, Aranguren A, Ruiz J, Prieto J, Larrea E, Melero I.

Eur J Immunol. 2010 Dec;40(12):3389-402. doi: 10.1002/eji.201040664.

46.

Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α.

Rouzaut A, Garasa S, Teijeira A, González I, Martinez-Forero I, Suarez N, Larrea E, Alfaro C, Palazón A, Dubrot J, Hervás-Stubbs S, Melero I.

Eur J Immunol. 2010 Nov;40(11):3054-63. doi: 10.1002/eji.201040523. Epub 2010 Oct 27.

47.

Life-threatening hyponatremia due to intravenous n-acetylcysteine treatment in an infant: a case report.

Mayordomo-Colunga J, Larrea E, García M, Suárez S, Rodríguez J.

Cases J. 2009 Sep 1;2:8347. doi: 10.4076/1757-1626-2-8347.

48.

Characterization of the human Nalpha-terminal acetyltransferase B enzymatic complex.

Ametzazurra A, Gázquez C, Lasa M, Larrea E, Prieto J, Aldabe R.

BMC Proc. 2009 Aug 4;3 Suppl 6:S4. doi: 10.1186/1753-6561-3-S6-S4.

49.

Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells.

Larrea E, Aldabe R, Gonzalez I, Segura V, Sarobe P, Echeverria I, Prieto J.

J Virol. 2009 Apr;83(7):3298-311. doi: 10.1128/JVI.02167-08. Epub 2009 Jan 21.

50.

Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis.

Ametzazurra A, Larrea E, Civeira MP, Prieto J, Aldabe R.

Oncogene. 2008 Dec 11;27(58):7296-306. doi: 10.1038/onc.2008.332. Epub 2008 Sep 15.

PMID:
18794801

Supplemental Content

Loading ...
Support Center